Daniel F. Vatner

3.4k total citations · 1 hit paper
33 papers, 2.4k citations indexed

About

Daniel F. Vatner is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Daniel F. Vatner has authored 33 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Daniel F. Vatner's work include Liver Disease Diagnosis and Treatment (15 papers), Diet, Metabolism, and Disease (11 papers) and Pancreatic function and diabetes (9 papers). Daniel F. Vatner is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Diet, Metabolism, and Disease (11 papers) and Pancreatic function and diabetes (9 papers). Daniel F. Vatner collaborates with scholars based in United States, Australia and Japan. Daniel F. Vatner's co-authors include Gerald I. Shulman, Max C. Petersen, Dongyan Zhang, Gary W. Cline, Varman T. Samuel, João Paulo Camporez, Rachel J. Perry, Leigh Goedeke, Kitt Falk Petersen and Yasmeen Rahimi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Daniel F. Vatner

31 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of hepatic glucose metabolism in health and disease

2017 810 citations Max C. Petersen, Daniel F. Vatner et al. Nature Reviews Endocrinology profile →

Peers

Daniel F. Vatner

EPIDE

EDM

PHYSI

SURGE

Paul M. Titchenell United States

Daniel Lindén Sweden

Fatiha Nassir United States

Archana Vijayakumar United States

Michał Pawlak Poland

Brennan K. Smith Canada

Xianqin Qu Australia

Katarina Marcinko Canada

Myoung Sook Han United States

Seiichiro Kurita Japan

Paul M. Titchenell United States

Daniel F. Vatner

1.5k ×1.4

988 ×1.1

EPIDE

754 ×0.9

EDM

992 ×1.7

PHYSI

558 ×1.1

SURGE

Citations per year, relative to Daniel F. Vatner Daniel F. Vatner (= 1×) peers Paul M. Titchenell

Countries citing papers authored by Daniel F. Vatner

Since Specialization

Citations

This map shows the geographic impact of Daniel F. Vatner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. Vatner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. Vatner more than expected).

Fields of papers citing papers by Daniel F. Vatner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel F. Vatner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. Vatner. The network helps show where Daniel F. Vatner may publish in the future.

Co-authorship network of co-authors of Daniel F. Vatner

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. Vatner. A scholar is included among the top collaborators of Daniel F. Vatner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. Vatner. Daniel F. Vatner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siebel, Stephan, et al.. (2025). Elevation of hepatic de novo lipogenesis in mice with overnutrition is dependent on multiple substrates. Journal of Lipid Research. 66(7). 100838–100838. 1 indexed citations

Slusher, Aaron L., Nicola Santoro, Alfonso Galderisi, et al.. (2025). ATGL links insulin dysregulation to insulin resistance in adolescents with obesity and hepatosteatosis. Journal of Clinical Investigation. 135(6).

Goedeke, Leigh, Jillian C. Rogers, Max C. Petersen, et al.. (2024). High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis. iScience. 27(11). 111175–111175. 1 indexed citations

Bini, Jason, Michael Kapinos, Ming‐Qiang Zheng, et al.. (2024). Quantification of Multi-Organ 11β-Hydroxysteroid Dehydrogenase Type 1 Enzyme Levels in a Zucker Fatty Rat Model: A PET Imaging Study. Molecular Imaging. 23. 885481552–885481552.

Sakuma, Ikki, Rafael Calais Gaspar, Panu K. Luukkonen, et al.. (2023). Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition. Proceedings of the National Academy of Sciences. 120(52). e2312666120–e2312666120. 10 indexed citations

Slusher, Aaron L., Fuyuze Tokoglu, Zhongyao Li, et al.. (2023). Rising NAFLD and metabolic severity during the Sars‐CoV‐2 pandemic among children with obesity in the United States. Obesity. 31(5). 1383–1391. 4 indexed citations

Schumann, Tina, Jörg König, Christian von Loeffelholz, et al.. (2021). Deletion of the diabetes candidate gene Slc16a13 in mice attenuates diet-induced ectopic lipid accumulation and insulin resistance. Communications Biology. 4(1). 826–826. 14 indexed citations

Nozaki, Yuichi, Max C. Petersen, Dongyan Zhang, et al.. (2020). Metabolic control analysis of hepatic glycogen synthesis in vivo. Proceedings of the National Academy of Sciences. 117(14). 8166–8176. 64 indexed citations

Abulizi, Abudukadier, Daniel F. Vatner, Yongliang Wang, et al.. (2020). Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice. Journal of Lipid Research. 61(12). 1565–1576. 14 indexed citations

10.

Zhang, Dongyan, Daniel F. Vatner, Leigh Goedeke, et al.. (2020). Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice. Proceedings of the National Academy of Sciences. 117(51). 32584–32593. 110 indexed citations

11.

Aryal, Binod, Abhishek K. Singh, Xinbo Zhang, et al.. (2018). Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis. JCI Insight. 3(6). 101 indexed citations

12.

Vatner, Daniel F., Leigh Goedeke, João Paulo Camporez, et al.. (2018). Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia. 61(6). 1435–1446. 62 indexed citations

13.

Madiraju, Anila K., Yang Qiu, Rachel J. Perry, et al.. (2018). Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nature Medicine. 24(9). 1384–1394. 222 indexed citations

14.

Abulizi, Abudukadier, João Paulo Camporez, Dongyan Zhang, et al.. (2018). Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice. Metabolism. 93. 1–9. 15 indexed citations

15.

Liu, Dongqing, John Sterpka, Daniel F. Vatner, et al.. (2018). Targeting Ketohexokinase (KHK) with a Novel Antisense Oligonucleotide (ASO) Decreases De Novo Lipogenesis and Improves Insulin-Mediated Whole Body Glucose Metabolism. Diabetes. 67(Supplement_1). 2 indexed citations

16.

Vatner, Daniel F., Max C. Petersen, Jillian C. Rogers, et al.. (2018). Evidence against Pathway-Selective Hepatic Insulin Resistance in Mice. Diabetes. 67(Supplement_1). 3 indexed citations

17.

Petersen, Max C., Daniel F. Vatner, & Gerald I. Shulman. (2017). Regulation of hepatic glucose metabolism in health and disease. Nature Reviews Endocrinology. 13(10). 572–587. 810 indexed citations breakdown →

18.

Vatner, Daniel F., et al.. (2015). 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats. PLoS ONE. 10(10). e0140837–e0140837. 15 indexed citations

19.

Kumashiro, Naoki, Toru Yoshimura, Jennifer Cantley, et al.. (2012). Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. Hepatology. 57(5). 1763–1772. 75 indexed citations

20.

Vatner, Daniel F., et al.. (1988). One hour of myocardial ischemia in conscious dogs increases β-adrenergic receptors, but decreases adenylate cyclase activity. Journal of Molecular and Cellular Cardiology. 20(1). 75–82. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact